Pierre Major - Concepedia

Author

Pierre Major

Also Known As

P MAJOR, P Major, P P Major, P. MAJOR, P. Major, P. P. Major, P.P. Major, PIERRE P. MAJOR, Paul Major, Philippa J. Major

235

Publications

9.2K

Citations

H-Index

145

Concepts

All Affiliations

McMaster University Juravinski Cancer Centre Dana-Farber Cancer Institute Massachusetts General Hospital Harvard University

About

Pierre Major is an author at McMaster University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	44	2.2K
2	Natural Sciences	11	12	1.1K
3	Health Sciences	10	10	368
4	Engineering	4	4	117
5	Social Sciences	1	1	42

Pierre Major

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials Pierre Major, Alain Lortholary, Jeremy K. Hon, Journal of Clinical Oncology	2001	851
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer William U. Shipley, Wendy Seiferheld, Himanshu Lukka, New England Journal of Medicine	2017	648
Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors J. E. Brown, Richard J. Cook, Pierre Major, JNCI Journal of the National Cancer Institute	2005	564
Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid Robert E. Coleman, Pierre Major, Allan Lipton, Journal of Clinical Oncology	2005	531
Correlation of cytotoxicity with incorporation of ara-C into DNA. Donald Küfe, Pierre Major, E.Michael Egan, Journal of Biological Chemistry Dna DamageImmunologyCell DeathMolecular BiologyNucleic Acid Amplification Test	1980	362
Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion Lee S. Rosen, David Gordon, William Dugan, Cancer	2003	333
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid Allan Lipton, Richard J. Cook, Fred Saad, Cancer	2008	271
Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA. Pierre Major, E.Michael Egan, G. Peter Beardsley, Proceedings of the National Academy of Sciences Hematological MalignancyChromatinHuman MyeloblastsL1210 DnaNatural Sciences	1981	201
5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. Donald Küfe, Pierre Major Journal of Biological Chemistry Breast OncologyPathologyMolecular BiologyCancer Biology5-Fluorouracil Incorporation	1981	191
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer Carol Townsley, Pierre Major, Lillian L. Siu, British Journal of Cancer	2006	176

Page 1